Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
Globenewswire -
Globenewswire -
Globenewswire -
Globenewswire -
Globenewswire -